Research is Better When People with SCI Help Design It

For far too many years, spinal cord injury researchers have failed to include disabled people in their studies as anything but subjects.  Fortunately, that’s changing as more people with SCI/D participate in consumer advisory boards and other human-focused approaches. They are designing surveys, focusing on goals and giving key input before a solution that impacts them is…

February 2021 cover of Movement Disorders, the official journal of the International Parkinson and Movement Disorder Society

FES Investigator, Aasef Shaikh, MD, PhD’s research, “Severity‐Dependent Effects of Parkinson’s Disease on Perception of Visual and Vestibular Heading” is featured on the February 2021 cover of Movement Disorders, the official journal of the International Parkinson and Movement Disorder Society. Read full article>>

Case-Coulter Translational Research Partnership awards $1.1 million in funding and support for promising biomedical engineering university technologies

The Case-Coulter Translational Research Partnership (CCTRP) has announced more than $1.1 million in funding and other support for six biomedical technologies. FES Investigators, Dustin Tyler, the Kent H. Smith Professor of Biomedical Engineering, Emily Graczyk, research assistant professor of biomedical engineering, and Jennifer Sweet, professor of neurological surgery were among the awards for, “Minimally Invasive…

University Hospitals and Louis Stokes Cleveland VA Medical Center doctor leads international task force in writing telemedicine guidelines for triaging dizziness symptoms

Created to help decision-making during COVID, guidelines may prove useful after pandemic CLEVELAND — One out of five people experience dizziness at least once every year. It is so bad in some people that there are about 4 million visits for treatment of dizziness in US emergency rooms each year. Dizziness is a symptom that…

Research Finds MyoPro® Delivers Meaningful Improvements in Motor Function for Brain Injury Patient

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that new published research measuring the benefits of the Company’s MyoPro myoelectric orthosis found “Despite long-standing traumatic brain injury, meaningful improvements in motor function were observed.”